Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 431.24 | 404.64 | 442.20 | 394.50 |
Depreciation/ Depletion | 182.61 | 117.09 | 64.71 | 42.99 |
Non- Cash Items | 71.66 | 22.75 | -15.45 | 1.09 |
Changesin Working Capital | -199.49 | -245.25 | -113.19 | -63.21 |
Cashfrom Operating Activities | 486.01 | 299.23 | 378.26 | 375.36 |
Capital Expenditures | -129.16 | -841.42 | -121.03 | -25.76 |
Other Investing Cash Flow Items Total | -1,725.36 | -140.68 | -198.58 | -297.60 |
Cashfrom Investing Activities | -1,854.52 | -982.10 | -319.61 | -323.36 |
Financing Cash Flow Items | -87.58 | -23.43 | -3.32 | -1.78 |
Total Cash Dividends Paid | 0.00 | -99.91 | -81.62 | -74.68 |
Issuance( Retirement)of Stock Net | 4.54 | 2.28 | 6.75 | 0.00 |
Issuance( Retirement)of Debt Net | 1,462.81 | 809.09 | 33.50 | -5.94 |
Cashfrom Financing Activities | 1,379.78 | 688.03 | -44.70 | -82.40 |
Net Changein Cash | 11.26 | 5.15 | 13.96 | -30.39 |
Cash Interest Paid | 77.30 | 23.43 | 3.85 | 1.78 |
Cash Taxes Paid | 100.75 | 77.21 | 83.29 | 68.54 |
Eris Lifesciences Dividend Eris Lifesciences Bonus Eris Lifesciences News Eris Lifesciences AGM Eris Lifesciences Rights Eris Lifesciences Splits Eris Lifesciences Board Meetings Eris Lifesciences Key Metrics Eris Lifesciences Shareholdings Eris Lifesciences Profit Loss Eris Lifesciences Balance Sheet Eris Lifesciences Q1 Results Eris Lifesciences Q2 Results Eris Lifesciences Q3 Results Eris Lifesciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks